Smooth muscle cell outgrowth from coronary atherectomy specimens in vitro is associated with less time to restenosis and expression of a key transcription factor KLF5/BTEB2

Cardiology

Volumn 100, Issue 2, 2003, Pages 80-85

  Sakamoto, Hironosuke ^a   Sakamaki, Tetsuo ^a   Kanda, Tsugiyasu ^a   Hoshino, Yo Ichi ^a   Sawada, Yoshie ^a   Sato, Mahito ^a   Sato, Hiroko ^a   Oyama, Yuko ^a   Nakano, Akihiko ^a   Takase, Shin Ichi ^a   Hasegawa, Akira ^a   Nagai, Ryozo ^b   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherectomy; Cell culture; KLF5; Restenosis; Smooth muscle cell; Transcription factor

Indexed keywords

KRUPPEL LIKE ZINC FINGER TRANSCRIPTION FACTOR 5; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHERECTOMY; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CHRONOSEQUENCE; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; TISSUE CULTURE CELL; TISSUE SECTION; ZINC FINGER MOTIF;

AGED; ATHERECTOMY, CORONARY; CELLS, CULTURED; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; RISK FACTORS; STATISTICS; TIME FACTORS; TRANS-ACTIVATORS;

EID: 10744229591     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073043     Document Type: Article

References (26)

1. Landau C, Lange RA, Hillis DL: Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981-993.
2. Glagov S: Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994;89:2888-2891.
3. Nobuyoshi M, Kimura T, Mosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623.
4. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. Circulation 1988;77:361-371.
5. Ernst SMPG, van der Feltz TA, Bal ET, van Bogerijen L, van den Berg E, Ascoop CAPL, Prokker HWT: Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J 1987;57:220-225.
6. Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB, Gruentzig AR: Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-717.
7. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K: Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-439.
8. Liu MW, Roubin GS, King SB: Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-1387.
9. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF: Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-375.
10. Wentzel JJ, Kloet J, Andhyiswara I, Oomen JAF, Schuurbiers JCH, de Smet BJGL, Post MJ, de Kleijin D, Pasterkamp G, Borst C, Slager CJ, Krams R: Shear-stress and wall-stress regulation of vascular remodeling after balloon angioplasty: Effect of matrix metalloproteinase inhibition. Circulation 2001;104:91-94.
11. Schwartz RS, Topol EJ, Serruys PW, Sangiorgi G, Holmes DR: Artery size, neointima, and remodeling: Time for some standards. J Am Coll Cardiol 1998;32:2087-2094.
12. Currier JW, Faxon DP: Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
13. Hinohara T, Selmon MR, Robertson GC, Braden L, Simpson JB: Directional atherectomy: New approaches for treatment of obstructive coronary and peripheral vascular disease. Circulation 1990;81:IV79-IV91.
14. Hofling B, Welsch U, Heimerl J, Gonschior P, Bauriedel G: Analysis of atherectomy specimens. Am J Cardiol 1993;72:96E-107E.
15. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB: Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: A histopathologic study. J Am Coll Cardiol 1990;15:419-425.
16. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM: Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res 1993;73:223-231.
17. Schwartz RS, Holmes DR, Topol EJ: The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-1293.
18. Watanabe N, Kurabayashi M, Shimomura Y, Kawai-Kowase K, Hoshino Y, Manabe I, Watanabe M, Aikawa M, Kuro-o M, Suzuki T, Yazaki Y, Nagai R: BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res 1999;85:182-191.
19. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R: Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 2002;8:856-863.
20. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958;8:699-712.
21. Pickering JG, Weir L, Rosenfield K, Stetz J, Jekanowski J, Isner JM: Smooth muscle cell outgrowth from human atherosclerotic plaque: Implications for the assessment of lesion biology. J Am Coll Cardiol 1992;20:1430-1439.
22. Bauriedel G, Windstetter U, DeMaio SJ, Kandolf R, Hofling B: Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy. Circulation 1992;85:554-564.
23. Escaned J, de Jong M, Violaris AG, MacLeod DC, Umans VA, van Suylen RJ, de Feyter PJ, Verdouw PD, Serruys PW: Clinical and histological determinants of smooth-muscle cell outgrowth in cultured atherectomy specimens: Importance of thrombus organization. Coron Artery Dis 1993;4:883-890.
24. Simons M, Leclerc G, Safian RD, Isner JM, Weir L, Baim DS: Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N Engl J Med 1993;328:608-613.
25. Kawai-Kowase K, Kurabayashi M, Hoshino Y, Ohyama Y, Nagai R: Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ Res 1999;85:787-795.
26. Hoshino Y, Kurabayashi M, Kanda T, Hasegawa A, Sakamoto H, Okamoto E, Kowase K, Watanabe N, Manabe I, Suzuki T, Nakano A, Takase S, Wilcox JN, Nagai R: Regulated expression of the BTEB2 transcription factor in vascular smooth muscle cells: Analysis of developmental and pathological expression profiles shows implications as a predictive factor for restenosis. Circulation 2000;102:2528-2534.